Not applicableStudy completedNCT02099565
What this trial is testing
Observational Prospective Study OPTIMA II - Follow-up
Who this might be right for
Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
AstraZeneca 572
Showing 8 of 8 results